Question

Albuterol basically differs from sympathomimetic in that the hydroxyl group at C-3 of the aromatic ring is replaced with ________ group.

• A. hydroxymethyl
• B. hydroxyethyl
• C. hydroxypropyl
• D. hydroxybutyl

Hint:

Replacing the meta-hydroxyl group of a catechol ring with a hydroxymethyl group creates a "saligenin" derivative (like salbutamol/albuterol). This alteration guarantees resistance to COMT degradation and preserves \(\beta_2\)-receptor selectivity!

Answer 1

The Correct Option is A

Concept: Endogenous catecholamines such as Epinephrine and Norepinephrine act as non-selective sympathomimetics that stimulate both alpha and beta-adrenergic receptors. Structurally, they feature a catechol ring—a benzene ring with hydroxyl (\(-\text{OH}\)) groups at the C-3 (meta) and C-4 (para) positions. A major disadvantage of catecholamines is their vulnerability to metabolic destruction by the enzyme Catechol-O-Methyltransferase (COMT), which methylates the C-3 hydroxyl group, rendering the drug inactive. This metabolic vulnerability leads to a short duration of action and prevents oral bioavailability.

Step 1: Analyzing the structural evolution of Albuterol (Salbutamol).
To develop long-acting, orally active, and highly selective \(\beta_2\)-adrenergic agonists for treating bronchial asthma, medicinal chemists modified the catechol ring to resist COMT degradation. In the design of Albuterol:
• The para-hydroxyl group at C-4 remains unchanged to maintain critical hydrogen-bonding capabilities with the receptor.
• The meta-hydroxyl group at the C-3 position of the benzene ring is replaced with a hydroxymethyl group (\(-\text{CH}_2\text{OH}\)).

Step 2: Understanding the impact of the hydroxymethyl modification.
This modification yields major therapeutic benefits:
• COMT Resistance: The enzyme COMT no longer recognizes the modified benzene ring as a substrate because the hydroxyl group is isolated by an extra methylene spacer (\(-\text{CH}_2-\)). This blocks metabolism, extending the drug's half-life and duration of action.
• Receptor Selectivity: The bulky hydroxymethyl group, combined with a tert-butyl substitution on the amino nitrogen, shifts receptor affinity away from cardiac \(\beta_1\) receptors and toward bronchial \(\beta_2\) receptors, reducing cardiovascular side effects like tachycardia. Conclusion: Reviewing the choices confirms that Albuterol replaces the standard C-3 aromatic hydroxyl group with a hydroxymethyl group.